Belvedere Trading »

Peregrine Pharmaceuticals shares owned by Belvedere Trading

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2024-03-31 $127k 19k 6.70

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A Put Option (META)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Apple (AAPL)
Amazon (AMZN)
Spdr Gold Tr Gold Shs Put Option (GLD)
Microstrategy Cl A New Put Option (MSTR)
Ishares Silver Tr Ishares (SLV)
Coinbase Global Com Cl A (COIN)
Super Micro Computer (SMCI)
Graniteshares Etf Tr 2x Long Nvda Dai Call Option (NVDL)
Etf Opportunities Trust T Rex 2x Long (NVDX)

View all positions for Belvedere Trading

Top funds holding Peregrine Pharmaceuticals

BlackRock
Millennium Management
Vanguard Group
AltraVue Capital
12 West Capital Management
Royal Bank of Canada
Snyder Capital Management
Palisade Capital Management
Citadel Advisors
Point72 Asset Management
Newtyn Management
Wellington Management Company
Geode Capital Management
Morgan Stanley
Punch & Associates Investment Management

View all funds holding Peregrine Pharmaceuticals